Nelangi M Pinto1, Richard Nelson2, Lorenzo Botto3, Michael D Puchalski1, Sergey Krikov3, Jaewhan Kim2, Norman J Waitzman4. 1. Division of Pediatric Cardiology, Department of Pediatrics, University of Utah, Salt Lake City, Utah. 2. Division of Epidemiology, Department of Internal Medicine, University of Utah, Salt Lake City, Utah. 3. Division of Genetics, Department of Pediatrics, University of Utah, Salt Lake City, Utah. 4. Department of Economics, University of Utah, Salt Lake City, Utah.
Abstract
BACKGROUND: The impact of prenatal diagnosis of d-transposition of the great arteries (dTGA) on health-care usage is largely unknown. We evaluated a population-based cohort to assess costs, mortality and inpatient encounters by whether dTGA was prenatally diagnosed or not. METHODS: The dTGA cases (born 1997-2011) identified at the Utah Birth Defect Network, which includes data on timing of diagnosis, were linked to statewide inpatient discharge data. We excluded preterm cases or cases with additional major heart defects. We evaluated hospitalizations and costs for infants (first year of life) and mothers (10 months before birth) using multivariable models adjusted for demographic and clinical risk factors. RESULTS: Of 119 cases, 14 (12%) were prenatally diagnosed. Birth weight, surgical complexity and extracardiac defects/syndromes were similar between groups. Of 7 deaths (6%), two occurred pre-intervention in postnatally diagnosed infants. Prenatal diagnosis was associated with more in-hospital days (estimate 13 additional days, p = 0.03) and higher mean costs for mothers ($4,141 vs $12,148) and infants (90,419 vs $49,576). Prenatal diagnosis independently predicted higher adjusted costs for the overall cohort ($22,570, p = 0.045). After excluding deaths, total costs were no longer significantly different. CONCLUSION: Mothers of prenatally diagnosed infants with dTGA had higher inpatient costs compared with those postnatally diagnosed. Costs trended higher for their infants, although were not significantly different. Linkage of population-based surveillance systems and outcome databases can be a powerful tool to further explore the complex relationship of prenatal diagnosis to costs and outcomes in other types of congenital heart diseases. Birth Defects Research 109:262-270, 2017.
BACKGROUND: The impact of prenatal diagnosis of d-transposition of the great arteries (dTGA) on health-care usage is largely unknown. We evaluated a population-based cohort to assess costs, mortality and inpatient encounters by whether dTGA was prenatally diagnosed or not. METHODS: The dTGA cases (born 1997-2011) identified at the Utah Birth Defect Network, which includes data on timing of diagnosis, were linked to statewide inpatient discharge data. We excluded preterm cases or cases with additional major heart defects. We evaluated hospitalizations and costs for infants (first year of life) and mothers (10 months before birth) using multivariable models adjusted for demographic and clinical risk factors. RESULTS: Of 119 cases, 14 (12%) were prenatally diagnosed. Birth weight, surgical complexity and extracardiac defects/syndromes were similar between groups. Of 7 deaths (6%), two occurred pre-intervention in postnatally diagnosed infants. Prenatal diagnosis was associated with more in-hospital days (estimate 13 additional days, p = 0.03) and higher mean costs for mothers ($4,141 vs $12,148) and infants (90,419 vs $49,576). Prenatal diagnosis independently predicted higher adjusted costs for the overall cohort ($22,570, p = 0.045). After excluding deaths, total costs were no longer significantly different. CONCLUSION: Mothers of prenatally diagnosed infants with dTGA had higher inpatient costs compared with those postnatally diagnosed. Costs trended higher for their infants, although were not significantly different. Linkage of population-based surveillance systems and outcome databases can be a powerful tool to further explore the complex relationship of prenatal diagnosis to costs and outcomes in other types of congenital heart diseases. Birth Defects Research 109:262-270, 2017.
Authors: M J Raboisson; C Samson; C Ducreux; R C Rudigoz; P Gaucherand; P Bouvagnet; A Bozio Journal: Eur J Obstet Gynecol Reprod Biol Date: 2008-11-20 Impact factor: 2.435
Authors: Anne C Kirchhoff; Mark N Fluchel; Jennifer Wright; Jian Ying; Carol Sweeney; Julia Bodson; Antoinette M Stroup; Ken R Smith; Alison Fraser; Anita Y Kinney Journal: Cancer Epidemiol Biomarkers Prev Date: 2014-06-12 Impact factor: 4.254
Authors: C L van Velzen; M C Haak; G Reijnders; M E B Rijlaarsdam; C J Bax; E Pajkrt; J Hruda; F Galindo-Garre; C M Bilardo; C J M de Groot; N A Blom; S A Clur Journal: Ultrasound Obstet Gynecol Date: 2015-01-27 Impact factor: 7.299
Authors: Anusha Jegatheeswaran; Carol Oliveira; Constantine Batsos; Anita J Moon-Grady; Norman H Silverman; Lisa K Hornberger; Peter Coyte; Mark K Friedberg Journal: Am J Cardiol Date: 2011-09-10 Impact factor: 2.778
Authors: P A Hutter; D L Kreb; S F Mantel; J F Hitchcock; E J Meijboom; G B W E Bennink Journal: J Thorac Cardiovasc Surg Date: 2002-10 Impact factor: 5.209
Authors: Mark K Friedberg; Norman H Silverman; Anita J Moon-Grady; Elizabeth Tong; Jennifer Nourse; Beatrice Sorenson; Jaimie Lee; Lisa K Hornberger Journal: J Pediatr Date: 2009-04-24 Impact factor: 4.406
Authors: Sharon H Wong; Kirsten Finucane; Alan R Kerr; Clare O'Donnell; Teena West; Thomas L Gentles Journal: Heart Lung Circ Date: 2007-07-31 Impact factor: 2.975
Authors: Jane Bell; Natasha Nassar; Robin Turner; Carol Bower; David Gillett; Wilma McBain; Camille Raynes-Greenow Journal: J Paediatr Child Health Date: 2015-11-26 Impact factor: 1.954